Related content

Tumour suppressors-a fly's perspective

By Sutcliffe J.E.   Korenjak M.   Brehm A.  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1355-1362

Elsevier

Access to resources Recommend Favorite

Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group

By Keilholz U.   Willhauck M.   Rimoldi D.   Brasseur F.   Dummer W.   Rass K.   de Vries T.   Blaheta J.   Voit C.   Lethe B.   Burchill S.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 750-753

Elsevier

Access to resources Recommend Favorite

Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1821-1830

Spandidos Publications

Access to resources Recommend Favorite

RNA Interference: A New Targeted Tumour Therapy?

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 11-17

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour markers in prostate cancer III: Biomarkers in urine

By Roobol Monique J.   Haese Alexander   Bjartell Anders  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 85-89

Informa Healthcare

Access to resources Recommend Favorite